SCNI Stock Analysis: Buy, Sell, or Hold?
SCNI - Scinai Immunotherapeutics Ltd. American Depositary Shares
$0.98
0.01 (1.03%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Nov 28, 2025
0d
Get Alerted When SCNI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called SCNI this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SCNI shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: SCNI shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SCNI is currently trading at $0.98, which is considered extended relative to its 30-day fair value range of $0.73 to $0.97.
Technical Outlook: Technically, SCNI is in a strong downtrend. Immediate support is located at $0.78, while resistance sits at $1.12.
Market Sentiment: SCNI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $700.00 (+72064.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SCNI is in a strong downtrend. Immediate support is located at $0.78, while resistance sits at $1.12.
Market Sentiment: SCNI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $700.00 (+72064.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.73 -
$0.97
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 72064.9% below Wall St target ($700.00)
Fair Price Analysis
30-Day Fair Range
$0.73 -
$0.97
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$0.78
Resistance Level
$1.12
Current Trend
Strong Downtrend
Fundamental Context
Wall Street Target
$700.00
(+72064.9%)
Revenue Growth (YoY)
36.1%
Earnings Growth (YoY)
87.2%
Profit Margin
448.4%
Last updated: January 31, 2026 2:43 PM ET
Data refreshes hourly during market hours. Next update: 3:43 PM
Data refreshes hourly during market hours. Next update: 3:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SCNI showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
Advanced SCNI Option Strategies
Professional options setups generated by AI based on today's SCNI price and gamma walls.